Detecting maternal-fetal genotype interactions associated with conotruncal heart defects: A haplotype-based analysis with penalized logistic regression

Genetic Epidemiology

Volumn 38, Issue 3, 2014, Pages 198-208

  Li, Ming ^a   Erickson, Stephen W ^a   Hobbs, Charlotte A ^a   Li, Jingyun ^a   Tang, Xinyu ^a   Nick, Todd G ^a   Macleod, Stewart L ^a   Cleves, Mario A ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Adaptive LASSO; Congenital heart defects; Maternal fetal interactions; National Birth Defects Prevention Study

Indexed keywords

AHCYL2 PROTEIN; GCLC PROTEIN; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE M3; MANGANESE SUPEROXIDE DISMUTASE; MTRR PROTEIN; PROTEIN; RFC1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONGENITAL HEART MALFORMATION; CONOTRUNCAL HEART DEFECT; EPISTASIS; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE INTERACTION; GENE MAPPING; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; MATERNAL FETAL GENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTIVE LASSO; CONGENITAL HEART DEFECTS; MATERNAL-FETAL INTERACTIONS; NATIONAL BIRTH DEFECTS PREVENTION STUDY;

ADULT; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; FETUS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEART DEFECTS, CONGENITAL; HUMANS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MATERNAL-FETAL EXCHANGE; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; QUALITY CONTROL; UNITED STATES;

EID: 84895925028     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21793     Document Type: Article

References (47)

1. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. 2012. An integrated map of genetic variation from 1, 092 human genomes. Nature 491(7422):56-65.
2. Ainsworth HF, Unwin J, Jamison DL, Cordell HJ. 2011. Investigation of maternal effects, maternal-fetal interactions and parent-of-origin effects (imprinting), using mothers and their offspring. Genet Epidemiol 35(1):19-45.
3. Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, Peltonen L and others. 2010. Integrating common and rare genetic variation in diverse human populations. Nature 467(7311):52-58.
4. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265.
5. Botto LD, Yang Q. 2000. 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151(9):862-877.
6. Campolo J, Penco S, Bianchi E, Colombo L, Parolini M, Caruso R, Sedda V, Patrosso MC, Cighetti G, Marocchi A and others. 2007. Glutamate-cysteine ligase polymorphism, hypertension, and male sex are associated with cardiovascular events. Biochemical and genetic characterization of Italian subpopulation. Am Heart J 154(6):1123-1129.
7. Childs EJ, Palmer CG, Lange K, Sinsheimer JS. 2010. Modeling maternal-offspring gene-gene interactions: the extended-MFG test. Genet Epidemiol 34(5): 512-521.
8. Chowdhury S, Hobbs CA, MacLeod SL, Cleves MA, Melnyk S, James SJ, Hu P, Erickson SW. 2012. Associations between maternal genotypes and metabolites implicated in congenital heart defects. Mol Genet Metab 107(3):596-604.
9. Cockerham CC. 1954. An extension of the concept of partitioning hereditary variance for analysis of covariances among relatives when epistasis is present. Genetics 39(6):859-882.
10. Coles BF, Kadlubar FF. 2005. Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol 401:9-42.
11. Cordell HJ. 2009. Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet 10(6):392-404.
12. Cui Y, Fu W, Sun K, Romero R, Wu R. 2007. Mapping nucleotide sequences that encode complex binary disease traits with HapMap. Curr Genomics 8(5):307-322.
13. Gallagher ML, Sturchio C, Smith A, Koontz D, Jenkins MM, Honein MA, Rasmussen SA. 2011. Evaluation of mailed pediatric buccal cytobrushes for use in a case-control study of birth defects. Birth Defects Res A Clin Mol Teratol 91(7):642-648.
14. Goldmuntz E, Woyciechowski S, Renstrom D, Lupo PJ, Mitchell LE. 2008. Variants of folate metabolism genes and the risk of conotruncal cardiac defects. Circ Cardiovasc Genet 1(2):126-132.
15. Hobbs CA, James SJ, Jernigan S, Melnyk S, Lu Y, Malik S, Cleves MA. 2006. Congenital heart defects, maternal homocysteine, smoking, and the 677 C>T polymorphism in the methylenetetrahydrofolate reductase gene: evaluating gene-environment interactions. Am J Obstet Gynecol 194(1):218-224.
16. Hobbs CA, MacLeod SL, Jill James S, Cleves MA. 2011. Congenital heart defects and maternal genetic, metabolic, and lifestyle factors. Birth Defects Res A Clin Mol Teratol 91(4):195-203.
17. Hoffman JI, Kaplan S. 2002. The incidence of congenital heart disease. J Am Coll Cardiol 39(12):1890-900.
18. Kao CH, Zeng ZB. 2002. Modeling epistasis of quantitative trait loci using Cockerham's model. Genetics 160(3):1243-1261.
19. Koide S, Kugiyama K, Sugiyama S, Nakamura S, Fukushima H, Honda O, Yoshimura M, Ogawa H. 2003. Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. J Am Coll Cardiol 41(4):539-545.
20. Kulich V, Kout M. 1967. Hemolytic disease of a newborn caused by anti-k antibody. Cesk Pediatr 22(9):823-826.
21. Li M, Romero R, Fu WJ, Cui Y. 2010. Mapping haplotype-haplotype interactions with adaptive LASSO. BMC Genet 11:79.
22. Li S, Lu Q, Fu W, Romero R, Cui Y. 2009. A regularized regression approach for dissecting genetic conflicts that increase disease risk in pregnancy. Stat Appl Genet Mol Biol 8:Article 45.
23. Lin M, Li H, Hou W, Johnson JA, Wu R. 2007. Modeling sequence-sequence interactions for drug response. Bioinformatics 23(10):1251-1257.
24. Liu T, Johnson JA, Casella G, Wu R. 2004. Sequencing complex diseases With HapMap. Genetics 168(1):503-511.
25. Liu T, Thalamuthu A, Liu JJ, Chen C, Wang Z, Wu R. 2011. Asymptotic distribution for epistatic tests in case-control studies. Genomics 98(2):145-151.
26. Lupo PJ, Goldmuntz E, Mitchell LE. 2010. Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects. J Biomed Biotechnol 2010:630940.
27. Moore JH. 2003. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 56(1-3):73-82.
28. Palmer CG, Turunen JA, Sinsheimer JS, Minassian S, Paunio T, Lonnqvist J, Peltonen L, Woodward JA. 2002. RHD maternal-fetal genotype incompatibility increases schizophrenia susceptibility. Am J Hum Genet 71(6):1312-1319.
29. Polimanti R, Piacentini S, Lazzarin N, Vaquero E, Re MA, Manfellotto D, Fuciarelli M. 2012. Glutathione S-transferase genes and the risk of recurrent miscarriage in Italian women. Fertil Steril 98(2):396-400.
30. Rasmussen SA, Lammer EJ, Shaw GM, Finnell RH, McGehee RE, Jr., Gallagher M, Romitti PA, Murray JC, National Birth Defects Prevention S. 2002. Integration of DNA sample collection into a multi-site birth defects case-control study. Teratology 66(4):177-184.
31. Relton CL, Wilding CS, Pearce MS, Laffling AJ, Jonas PA, Lynch SA, Tawn EJ, Burn J. 2004. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 41(4):256-260.
32. Shi M, Umbach DM, Vermeulen SH, Weinberg CR. 2008. Making the most of case-mother/control-mother studies. Am J Epidemiol 168(5):541-547.
33. Sinsheimer JS, Elston RC, Fu WJ. 2010. Gene-gene interaction in maternal and perinatal research. J Biomed Biotechnol 2010.
34. Sinsheimer JS, Palmer CG, Woodward JA. 2003. Detecting genotype combinations that increase risk for disease: maternal-fetal genotype incompatibility test. Genet Epidemiol 24(1):1-13.
35. Storey JD. 2002. A direct approach to false discovery rates. J Roy Stat Soc Ser B 64:479-498.
36. Tibshirani R. 1996. Regression shrinkage and selection via the Lasso. J Roy Stat Soc Ser B 58:267-288.
37. Umbach DM, Weinberg CR. 2000. The use of case-parent triads to study joint effects of genotype and exposure. Am J Hum Genet 66(1):251-261.
38. van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, Roos-Hesselink JW. 2011. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58(21):2241-2247.
39. van Gent T, Heijnen CJ, Treffers PD. 1997. Autism and the immune system. J Child Psychol Psychiatr 38(3):337-349.
40. Wang X, Morris NJ, Schaid DJ, Elston RC. 2012. Power of single- vs. multi-marker tests of association. Genet Epidemiol 36(5):480-487.
41. Weinberg CR, Wilcox AJ, Lie RT. 1998. A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 62(4):969-978.
42. Wessels MW, Willems PJ. 2010. Genetic factors in non-syndromic congenital heart malformations. Clin Genet 78(2):103-123.
43. Wilcox AJ, Weinberg CR, Lie RT. 1998. Distinguishing the effects of maternal and offspring genes through studies of "case-parent triads". Am J Epidemiol 148(9):893-901.
44. Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P, Druschel C, Hobbs CA, Romitti PA, et al. 2001. The national birth defects prevention study. Public Health Rep 116 Suppl 1:32-40.
45. Zandi PP, Kalaydjian A, Avramopoulos D, Shao H, Fallin MD, Newschaffer CJ. 2006. Rh and ABO maternal-fetal incompatibility and risk of autism. Am J Med Genet B Neuropsychiatr Genet 141B(6):643-647.
46. Zhang L, Liu R, Wang Z, Culver DA, Wu R. 2012. Modeling haplotype-haplotype interactions in case-control genetic association studies. Front Genet 3:2.
47. Zou H. 2006. The adaptive LASSO and its oracle properties. JASA 101:1418-1429.